Ultragenyx Pharmaceutical
Robert Schilt is a seasoned professional in quality assurance and regulatory affairs, currently serving as Senior Director Quality Assurance and Qualified Person at Ultragenyx since May 2019. Additionally, Schilt has been a technical expert at the Dutch Accreditation Council since February 2013 and operates Isdimma Consultancy, focusing on quality control audits. Previous roles include Senior Consultant GMP at ProPharma Group, Head of Quality Control a.i. at uniQure, and interim management positions in organizations such as Janssen and SynCo Bio Partners. Schilt's extensive experience spans over two decades in the pharmaceutical and veterinary medicine sectors, supported by an MSc in Pharmacy from Leiden University.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.